{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:11:13Z","timestamp":1793106673619,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001786","name":"The University of Adelaide","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer stem cells play an important role in tumor progression and chemotherapy resistance. Leucine-rich G repeat-containing protein-coupled receptor 5 (LGR5) has been identified as a cancer stem cell marker in several cancer types. LGR5 is involved in cancer development and progression via several pathways including WNT\/\u03b2-catenin signaling pathway. LGR5 plays a role in tumor progression by promoting cancer cell migration, invasion, metastasis, and angiogenesis in many cancers including colorectal, brain, gastric, and ovarian cancer. This review summarises the current knowledge on the expression and functional role of LGR5 in cancers, the molecular mechanisms regulated by LGR5, and the relationship between LGR5 and chemotherapy resistance. The review also includes highlights potential strategies to inhibit LGR5 expression and function. The majority of functional studies have shown that LGR5 plays an important role in promoting cancer progression, metastasis and chemotherapy resistance however, in some contexts LGR5 can also activate tumor-suppressive pathways and LGR5\u00a0negative cells can also promote cancer progression. The review highlights that targeting LGR5 is a promising anti-cancer treatment but the functional effect of LGR5 on tumor cells is complex may be dependent on cancer type, tumor microenvironment and cross-talk with other molecules in the LGR5 signaling pathway.<\/jats:p>","DOI":"10.1007\/s10555-024-10239-x","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:50:42Z","timestamp":1737093042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance"],"prefix":"10.1007","volume":"44","author":[{"given":"Wanqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor A.","family":"Lokman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"8","key":"10239_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2(8), 563\u2013572. https:\/\/doi.org\/10.1038\/nrc865","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10239_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13048-018-0439-3","volume":"11","author":"SC Parte","year":"2018","unstructured":"Parte, S. C., Batra, S. K., & Kakar, S. S. (2018). Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors. Journal of Ovarian Research, 11(1), 69. https:\/\/doi.org\/10.1186\/s13048-018-0439-3","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"10239_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024). Cancer stem cells: Advances in knowledge and implications for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 170. https:\/\/doi.org\/10.1038\/s41392-024-01851-y","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"10","key":"10239_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E., & Clevers, H. (2017). Cancer stem cells revisited. Nature Medicine, 23(10), 1124\u20131134. https:\/\/doi.org\/10.1038\/nm.4409","journal-title":"Nature Medicine"},{"key":"10239_CR5","doi-asserted-by":"publisher","unstructured":"Bahmad, H. F., Chamaa, F., Assi, S., Chalhoub, R. M., Abou-Antoun, T., & Abou-Kheir, W. (2019). Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier [Review]. Frontiers in Molecular Neuroscience, 12(131). https:\/\/doi.org\/10.3389\/fnmol.2019.00131","DOI":"10.3389\/fnmol.2019.00131"},{"issue":"1","key":"10239_CR6","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018). Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. Stem Cells International, 2018(1), 5416923. https:\/\/doi.org\/10.1155\/2018\/5416923","journal-title":"Stem Cells International"},{"issue":"6","key":"10239_CR7","doi-asserted-by":"publisher","first-page":"189205","DOI":"10.1016\/j.bbcan.2024.189205","volume":"1879","author":"SK Panda","year":"2024","unstructured":"Panda, S. K., Robinson, N., & Desiderio, V. (2024). Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance. Biochimica et Biophysica Acta - Reviews on Cancer, 1879(6), 189205. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189205","journal-title":"Biochimica et Biophysica Acta - Reviews on Cancer"},{"key":"10239_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","volume":"44","author":"C Peitzsch","year":"2017","unstructured":"Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017). Cancer stem cells: The root of tumor recurrence and metastases. Seminars in Cancer Biology, 44, 10\u201324. https:\/\/doi.org\/10.1016\/j.semcancer.2017.02.011","journal-title":"Seminars in Cancer Biology"},{"issue":"1","key":"10239_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4081\/oncol.2019.410","volume":"13","author":"S Hasan","year":"2019","unstructured":"Hasan, S., Jacob, R., Manne, U., & Paluri, R. (2019). Advances in pancreatic cancer biomarkers. Oncology Reviews, 13(1), 410. https:\/\/doi.org\/10.4081\/oncol.2019.410","journal-title":"Oncology Reviews"},{"issue":"1","key":"10239_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.18632\/oncotarget.20178","volume":"9","author":"AJ Schindler","year":"2017","unstructured":"Schindler, A. J., Watanabe, A., & Howell, S. B. (2017). LGR5 and LGR6 in stem cell biology and ovarian cancer. Oncotarget, 9(1), 1346\u20131355. https:\/\/doi.org\/10.18632\/oncotarget.20178","journal-title":"Oncotarget"},{"key":"10239_CR11","doi-asserted-by":"crossref","unstructured":"Abdelrahman, A. E., El-azony, A., Elsebai, E., & Ibrahim, H. M. (2022). Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer. Applied Immunohistochemistry & Molecular Morphology, 30(2). https:\/\/journals.lww.com\/appliedimmunohist\/Fulltext\/2022\/02000\/Prognostic_Impact_of_LGR5,_Prox1,_and_Notch1.8.aspx","DOI":"10.1097\/PAI.0000000000000983"},{"issue":"9","key":"10239_CR12","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.31557\/apjcp.2021.22.9.2819","volume":"22","author":"H Morsy","year":"2021","unstructured":"Morsy, H., Gaballah, A., Samir, M., Nakundi, V., Shamseya, M., Mahrous, H., Ghazal, A., Hashish, M., & Arafat, W. (2021). LGR5, HES1 and ATOH1 in Young Rectal Cancer Patients in Egyptian. Asian Pacific Journal of Cancer Prevention, 22(9), 2819\u20132830. https:\/\/doi.org\/10.31557\/apjcp.2021.22.9.2819","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"1","key":"10239_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.21037\/tcr.2019.01.24","volume":"8","author":"F Gao","year":"2019","unstructured":"Gao, F., Xu, J. C., You, X. R., Gao, X., Wei, J. L., Li, S. X., Zhu, C. L., & Yang, C. (2019). The biological functions of LGR5 in promoting non-small cell lung cancer progression. Translational Cancer Research, 8(1), 203\u2013211. https:\/\/doi.org\/10.21037\/tcr.2019.01.24","journal-title":"Translational Cancer Research"},{"issue":"1","key":"10239_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024). G protein-coupled receptors (GPCRs): Advances in structures, mechanisms, and drug discovery. Signal Transduction and Targeted Therapy, 9(1), 88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"10239_CR15","first-page":"1783","volume":"8","author":"B Sun","year":"2015","unstructured":"Sun, B., Ye, X., Li, Y., & Zhang, W. (2015). Lgr5 is a potential prognostic marker in patients with cervical carcinoma. International Journal of Clinical and Experimental Pathology, 8(2), 1783\u20131789.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"5","key":"10239_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/pro.2446","volume":"23","author":"KK Kumar","year":"2014","unstructured":"Kumar, K. K., Burgess, A. W., & Gulbis, J. M. (2014). Structure and function of LGR5: An enigmatic G-protein coupled receptor marking stem cells. Protein Science, 23(5), 551\u2013565. https:\/\/doi.org\/10.1002\/pro.2446","journal-title":"Protein Science"},{"issue":"21","key":"10239_CR17","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1128\/MCB.01034-07","volume":"27","author":"T Fevr","year":"2007","unstructured":"Fevr, T., Robine, S., Louvard, D., & Huelsken, J. (2007). Wnt\/\u03b2-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells. Molecular and Cellular Biology, 27(21), 7551. https:\/\/doi.org\/10.1128\/MCB.01034-07","journal-title":"Molecular and Cellular Biology"},{"issue":"11","key":"10239_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N., & Boutros, M. (2017). Wnt signaling in cancer. Oncogene, 36(11), 1461\u20131473. https:\/\/doi.org\/10.1038\/onc.2016.304","journal-title":"Oncogene"},{"issue":"7165","key":"10239_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., & Clevers, H. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449(7165), 1003\u20131007. https:\/\/doi.org\/10.1038\/nature06196","journal-title":"Nature"},{"issue":"7","key":"10239_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41556-019-0339-9","volume":"21","author":"M Sigal","year":"2019","unstructured":"Sigal, M., Rein\u00e9s, Md. M., M\u00fcllerke, S., Fischer, C., Kapalczynska, M., Berger, H., Bakker, E. R. M., Mollenkopf, H.-J., Rothenberg, M. E., Wiedenmann, B., Sauer, S., & Meyer, T. F. (2019). R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach. Nature Cell Biology, 21(7), 812\u2013823. https:\/\/doi.org\/10.1038\/s41556-019-0339-9","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10239_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.celrep.2012.08.018","volume":"2","author":"N Barker","year":"2012","unstructured":"Barker, N., Rookmaaker, M. B., Kujala, P., Ng, A., Leushacke, M., Snippert, H., van de Wetering, M., Tan, S., Van Es, J. H., Huch, M., Poulsom, R., Verhaar, M. C., Peters, P. J., & Clevers, H. (2012). Lgr5(+ve) stem\/progenitor cells contribute to nephron formation during kidney development. Cell Reports, 2(3), 540\u2013552. https:\/\/doi.org\/10.1016\/j.celrep.2012.08.018","journal-title":"Cell Reports"},{"issue":"3","key":"10239_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/path.4096","volume":"228","author":"KE de Visser","year":"2012","unstructured":"de Visser, K. E., Ciampricotti, M., Michalak, E. M., Tan, D. W., Speksnijder, E. N., Hau, C. S., Clevers, H., Barker, N., & Jonkers, J. (2012). Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland. The Journal of Pathology, 228(3), 300\u2013309. https:\/\/doi.org\/10.1002\/path.4096","journal-title":"The Journal of Pathology"},{"issue":"7","key":"10239_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/molehr\/gat014","volume":"19","author":"C Gil-Sanchis","year":"2013","unstructured":"Gil-Sanchis, C., Cervell\u00f3, I., Mas, A., Faus, A., Pellicer, A., & Sim\u00f3n, C. (2013). Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) as a putative human endometrial stem cell marker. Molecular Human Reproduction, 19(7), 407\u2013414. https:\/\/doi.org\/10.1093\/molehr\/gat014","journal-title":"Molecular Human Reproduction"},{"issue":"8","key":"10239_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ncb3000","volume":"16","author":"A Ng","year":"2014","unstructured":"Ng, A., Tan, S., Singh, G., Rizk, P., Swathi, Y., Tan, T. Z., Huang, R.Y.-J., Leushacke, M., & Barker, N. (2014). Lgr5 marks stem\/progenitor cells in ovary and tubal epithelia. Nature Cell Biology, 16(8), 745\u2013757. https:\/\/doi.org\/10.1038\/ncb3000","journal-title":"Nature Cell Biology"},{"issue":"7","key":"10239_CR25","doi-asserted-by":"publisher","first-page":"e22077","DOI":"10.1371\/journal.pone.0022077","volume":"6","author":"M Noh","year":"2011","unstructured":"Noh, M., Smith, J. L., Huh, Y. H., & Sherley, J. L. (2011). A resource for discovering specific and universal biomarkers for distributed stem cells. PLoS ONE, 6(7), e22077. https:\/\/doi.org\/10.1371\/journal.pone.0022077","journal-title":"PLoS ONE"},{"issue":"8","key":"10239_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/ncb3020","volume":"16","author":"B Capel","year":"2014","unstructured":"Capel, B. (2014). Ovarian epithelium regeneration by Lgr5+ cells. Nature Cell Biology, 16(8), 743\u2013744. https:\/\/doi.org\/10.1038\/ncb3020","journal-title":"Nature Cell Biology"},{"issue":"10","key":"10239_CR27","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.18632\/aging.103237","volume":"12","author":"JN Mara","year":"2020","unstructured":"Mara, J. N., Zhou, L. T., Larmore, M., Johnson, B., Ayiku, R., Amargant, F., Pritchard, M. T., & Duncan, F. E. (2020). Ovulation and ovarian wound healing are impaired with advanced reproductive age. Aging (Albany NY), 12(10), 9686\u20139713. https:\/\/doi.org\/10.18632\/aging.103237","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10239_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1095\/biolreprod50.2.233","volume":"50","author":"LL Espey","year":"1994","unstructured":"Espey, L. L. (1994). Current Status of the Hypothesis that Mammalian Ovulation is Comparable to an Inflammatory Reaction. Biology of Reproduction, 50(2), 233\u2013238. https:\/\/doi.org\/10.1095\/biolreprod50.2.233","journal-title":"Biology of Reproduction"},{"issue":"34","key":"10239_CR29","doi-asserted-by":"publisher","first-page":"23809","DOI":"10.1074\/jbc.M114.568170","volume":"289","author":"D Liu","year":"2014","unstructured":"Liu, D., He, X. C., Qian, P., Barker, N., Trainor, P. A., Clevers, H., Liu, H., & Li, L. (2014). Leucine-rich repeat-containing G-protein-coupled Receptor 5 marks short-term hematopoietic stem and progenitor cells during mouse embryonic development. The Journal of biological chemistry, 289(34), 23809\u201323816. https:\/\/doi.org\/10.1074\/jbc.M114.568170","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"10239_CR30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/stem.2314","volume":"34","author":"K Boddupally","year":"2016","unstructured":"Boddupally, K., Wang, G., Chen, Y., & Kobielak, A. (2016). Lgr5 Marks Neural Crest Derived Multipotent Oral Stromal Stem Cells. Stem Cells, 34(3), 720\u2013731. https:\/\/doi.org\/10.1002\/stem.2314","journal-title":"Stem Cells"},{"issue":"10","key":"10239_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrm4056","volume":"16","author":"A Ng","year":"2015","unstructured":"Ng, A., & Barker, N. (2015). Ovary and fimbrial stem cells: Biology, niche and cancer origins. Nature Reviews Molecular Cell Biology, 16(10), 625\u2013638. https:\/\/doi.org\/10.1038\/nrm4056","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10239_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1101\/sqb.2008.72.003","volume":"73","author":"N Barker","year":"2008","unstructured":"Barker, N., van Es, J. H., Jaks, V., Kasper, M., Snippert, H., Toftgard, R., & Clevers, H. (2008). Very long-term self-renewal of small intestine, colon, and hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harbor Symposia on Quantitative Biology, 73, 351\u2013356. https:\/\/doi.org\/10.1101\/sqb.2008.72.003","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"issue":"5","key":"10239_CR33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1053\/j.gastro.2010.03.002","volume":"138","author":"N Barker","year":"2010","unstructured":"Barker, N., & Clevers, H. (2010). Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology, 138(5), 1681\u20131696. https:\/\/doi.org\/10.1053\/j.gastro.2010.03.002","journal-title":"Gastroenterology"},{"issue":"1","key":"10239_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2010.09.016","volume":"143","author":"HJ Snippert","year":"2010","unstructured":"Snippert, H. J., van der Flier, L. G., Sato, T., van Es, J. H., van den Born, M., Kroon-Veenboer, C., Barker, N., Klein, A. M., van Rheenen, J., Simons, B. D., & Clevers, H. (2010). Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell, 143(1), 134\u2013144. https:\/\/doi.org\/10.1016\/j.cell.2010.09.016","journal-title":"Cell"},{"issue":"1","key":"10239_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nmeth.2737","volume":"11","author":"X Yin","year":"2014","unstructured":"Yin, X., Farin, H. F., van Es, J. H., Clevers, H., Langer, R., & Karp, J. M. (2014). Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny. Nature Methods, 11(1), 106\u2013112. https:\/\/doi.org\/10.1038\/nmeth.2737","journal-title":"Nature Methods"},{"key":"10239_CR36","doi-asserted-by":"publisher","unstructured":"Barker, N., Huch, M., Kujala, P., van de Wetering, M., Snippert, H. J., van Es, J. H., Sato, T., Stange, D. E., Begthel, H., van den Born, M., Danenberg, E., van den Brink, S., Korving, J., Abo, A., Peters, P. J., Wright, N., Poulsom, R., & Clevers, H. (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell, 6(1), 25\u201336. https:\/\/doi.org\/10.1016\/j.stem.2009.11.013","DOI":"10.1016\/j.stem.2009.11.013"},{"issue":"16","key":"10239_CR37","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3748\/wjg.v29.i16.2380","volume":"29","author":"L Zheng","year":"2023","unstructured":"Zheng, L., & Duan, S. L. (2023). Molecular regulation mechanism of intestinal stem cells in mucosal injury and repair in ulcerative colitis. World Journal of Gastroenterology, 29(16), 2380\u20132396. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2380","journal-title":"World Journal of Gastroenterology"},{"issue":"7","key":"10239_CR38","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/cam4.1485","volume":"7","author":"W Liu","year":"2018","unstructured":"Liu, W., Zhang, J., Gan, X., Shen, F., Yang, X., Du, N., Xia, D., Liu, L., Qiao, L., Pan, J., Sun, Y., & Xi, X. (2018). LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial\u2013mesenchymal transition through the Notch1 signaling pathway. Cancer Medicine, 7(7), 3132\u20133142. https:\/\/doi.org\/10.1002\/cam4.1485","journal-title":"Cancer Medicine"},{"issue":"16","key":"10239_CR39","doi-asserted-by":"publisher","first-page":"26492","DOI":"10.18632\/oncotarget.15624","volume":"8","author":"Z Lv","year":"2017","unstructured":"Lv, Z., Yu, J. J., Zhang, W. J., Xiong, L., Wang, F., Li, L. F., Zhou, X. L., Gao, X. Y., Ding, X. F., Han, L., Cai, Y. F., Ma, W., & Wang, L. X. (2017). Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma. Oncotarget, 8(16), 26492\u201326504. https:\/\/doi.org\/10.18632\/oncotarget.15624","journal-title":"Oncotarget"},{"issue":"11","key":"10239_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00384-013-1721-x","volume":"28","author":"HC Hsu","year":"2013","unstructured":"Hsu, H. C., Liu, Y. S., Tseng, K. C., Hsu, C. L., Liang, Y., Yang, T. S., Chen, J. S., Tang, R. P., Chen, S. J., & Chen, H. C. (2013). Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. International Journal of Colorectal Disease, 28(11), 1535\u20131546. https:\/\/doi.org\/10.1007\/s00384-013-1721-x","journal-title":"International Journal of Colorectal Disease"},{"issue":"19","key":"10239_CR41","doi-asserted-by":"publisher","first-page":"9092","DOI":"10.18632\/oncotarget.2377","volume":"5","author":"Q Chen","year":"2014","unstructured":"Chen, Q., Cao, H. Z., & Zheng, P. S. (2014). LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt\/\u03b2-catenin signaling pathway. Oncotarget, 5(19), 9092\u20139105. https:\/\/doi.org\/10.18632\/oncotarget.2377","journal-title":"Oncotarget"},{"issue":"46","key":"10239_CR42","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.3748\/wjg.v19.i46.8714","volume":"19","author":"ZX Zheng","year":"2013","unstructured":"Zheng, Z. X., Sun, Y., Bu, Z. D., Zhang, L. H., Li, Z. Y., Wu, A. W., Wu, X. J., Wang, X. H., Cheng, X. J., Xing, X. F., Du, H., & Ji, J. F. (2013). Intestinal stem cell marker LGR5 expression during gastric carcinogenesis. World Journal of Gastroenterology, 19(46), 8714\u20138721. https:\/\/doi.org\/10.3748\/wjg.v19.i46.8714","journal-title":"World Journal of Gastroenterology"},{"key":"10239_CR43","unstructured":"Scannell, C. A., Pedersen Ea Fau - Mosher, J. T., Mosher Jt Fau - Krook, M. A., Krook Ma Fau - Nicholls, L. A., Nicholls La Fau - Wilky, B. A., Wilky Ba Fau - Loeb, D. M., Loeb Dm Fau - Lawlor, E. R., & Lawlor, E. R. LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt\/\u03b2-Catenin Signaling. (2234\u2013943X (Print))."},{"issue":"3","key":"10239_CR44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1053\/jhep.2003.50029","volume":"37","author":"Y Yamamoto","year":"2003","unstructured":"Yamamoto, Y., Sakamoto, M., Fujii, G., Tsuiji, H., Kenetaka, K., Asaka, M., & Hirohashi, S. (2003). Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Hepatology, 37(3), 528\u2013533. https:\/\/doi.org\/10.1053\/jhep.2003.50029","journal-title":"Hepatology"},{"issue":"7647","key":"10239_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D., Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H., Dijkgraaf, G. J. P., Piskol, R., & de Sauvage, F. J. (2017). A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature, 543(7647), 676\u2013680. https:\/\/doi.org\/10.1038\/nature21713","journal-title":"Nature"},{"issue":"2","key":"10239_CR46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12029-019-00295-w","volume":"51","author":"S Salehzadeh","year":"2020","unstructured":"Salehzadeh, S., Hasanzad, M., Kadijani, A. A., & Akbari, A. (2020). The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers. Journal of Gastrointestinal Cancer, 51(2), 591\u2013599. https:\/\/doi.org\/10.1007\/s12029-019-00295-w","journal-title":"Journal of Gastrointestinal Cancer"},{"issue":"2","key":"10239_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000431222","volume":"81","author":"Y Sun","year":"2016","unstructured":"Sun, Y., Jia, X., & Wu, X. (2016). High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients. Gynecologic and Obstetric Investigation, 81(2), 162\u2013168. https:\/\/doi.org\/10.1159\/000431222","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"1","key":"10239_CR48","first-page":"327","volume":"12","author":"L Yu","year":"2019","unstructured":"Yu, L., Mao, X., Wu, S., Zhou, L., Song, W., Gong, X., & Wang, D. (2019). The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance. International Journal of Clinical and Experimental Pathology, 12(1), 327.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"10","key":"10239_CR49","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s00432-020-03314-7","volume":"146","author":"A Gzil","year":"2020","unstructured":"Gzil, A., Zar\u0119bska, I., Jaworski, D., Antosik, P., Dur\u015blewicz, J., Maciejewska, J., Domanowska, E., Skoczylas-Makowska, N., Ahmadi, N., Grzanka, D., & Szylberg, \u0141. (2020). The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer. Journal of Cancer Research and Clinical Oncology, 146(10), 2547\u20132557. https:\/\/doi.org\/10.1007\/s00432-020-03314-7","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"10239_CR50","first-page":"87","volume":"26","author":"N Xu","year":"2021","unstructured":"Xu, N., Gao, K., Luo, H., Wu, Y., Shen, B., & Liu, K. (2021). Correlation of Lgr5 expression with clinicopathological features of colorectal cancer and its diagnostic and prognostic values. Journal of B.U.ON., 26(1), 87\u201392.","journal-title":"Journal of B.U.ON."},{"issue":"10","key":"10239_CR51","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41416-019-0442-5","volume":"120","author":"H Nagata","year":"2019","unstructured":"Nagata, H., Ishihara, S., Abe, H., Ushiku, T., Kishikawa, J., Tanaka, T., Hata, K., Kawai, K., Fukayama, M., & Nozawa, H. (2019). LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer. British Journal of Cancer, 120(10), 996\u20131002. https:\/\/doi.org\/10.1038\/s41416-019-0442-5","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10239_CR52","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41419-018-0776-6","volume":"9","author":"Q Wang","year":"2018","unstructured":"Wang, Q., Shi, Y. L., Zhou, K., Wang, L. L., Yan, Z. X., Liu, Y. L., Xu, L. L., Zhao, S. W., Chu, H. L., Shi, T. T., Ma, Q. H., & Bi, J. (2018). PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer. Cell Death & Disease, 9(7), 739. https:\/\/doi.org\/10.1038\/s41419-018-0776-6","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10239_CR53","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1021\/acs.bioconjchem.1c00008","volume":"32","author":"S Yu","year":"2021","unstructured":"Yu, S., Mulero, M. C., Chen, W., Shang, X., Tian, S., Watanabe, J., Watanabe, A., Vorberg, T., Wong, C., Gately, D., & Howell, S. B. (2021). Therapeutic Targeting of Tumor Cells Rich in LGR Stem Cell Receptors. Bioconjugate Chemistry, 32(2), 376\u2013384. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00008","journal-title":"Bioconjugate Chemistry"},{"issue":"12","key":"10239_CR54","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/0284186x.2016.1201215","volume":"55","author":"L Stanisavljevi\u0107","year":"2016","unstructured":"Stanisavljevi\u0107, L., Myklebust, M. P., Leh, S., & Dahl, O. (2016). LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica, 55(12), 1425\u20131433. https:\/\/doi.org\/10.1080\/0284186x.2016.1201215","journal-title":"Acta Oncologica"},{"issue":"1","key":"10239_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12885-015-1986-2","volume":"16","author":"Y Jiang","year":"2016","unstructured":"Jiang, Y., Li, W., He, X., Zhang, H., Jiang, F., & Chen, Z. (2016). Lgr5 expression is a valuable prognostic factor for colorectal cancer: Evidence from a meta-analysis. BMC Cancer, 16(1), 12. https:\/\/doi.org\/10.1186\/s12885-015-1986-2","journal-title":"BMC Cancer"},{"key":"10239_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fcell.2015.00077","volume":"3","author":"H Forgham","year":"2015","unstructured":"Forgham, H., Johnson, D., Carter, N., Veuger, S., & Carr-Wilkinson, J. (2015). Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5. Front Cell Dev Biol, 3, 77. https:\/\/doi.org\/10.3389\/fcell.2015.00077","journal-title":"Front Cell Dev Biol"},{"key":"10239_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.gene.2018.10.014","volume":"683","author":"S Shi","year":"2019","unstructured":"Shi, S., Chen, X., Liu, H., Yu, K., Bao, Y., Chai, J., Gao, H., & Zou, L. (2019). LGR5 acts as a target of miR-340\u20135p in the suppression of cell progression and drug resistance in breast cancer via Wnt\/\u03b2-catenin pathway. Gene, 683, 47\u201353. https:\/\/doi.org\/10.1016\/j.gene.2018.10.014","journal-title":"Gene"},{"issue":"9","key":"10239_CR58","doi-asserted-by":"publisher","first-page":"e3039","DOI":"10.1038\/cddis.2017.393","volume":"8","author":"H-Z Cao","year":"2017","unstructured":"Cao, H.-Z., Liu, X.-F., Yang, W.-T., Chen, Q., & Zheng, P.-S. (2017). LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer. Cell Death & Disease, 8(9), e3039\u2013e3039. https:\/\/doi.org\/10.1038\/cddis.2017.393","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10239_CR59","doi-asserted-by":"publisher","first-page":"CRC11","DOI":"10.2217\/crc-2019-0009","volume":"8","author":"C Ihemelandu","year":"2019","unstructured":"Ihemelandu, C., Naeem, A., Parasido, E., Berry, D., Chaldekas, K., Harris, B. T., Rodriguez, O., & Albanese, C. (2019). Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer. Colorectal cancer, 8(4), CRC11\u2013CRC11. https:\/\/doi.org\/10.2217\/crc-2019-0009","journal-title":"Colorectal cancer"},{"issue":"10","key":"10239_CR60","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.ajpath.2018.06.012","volume":"188","author":"BG Jang","year":"2018","unstructured":"Jang, B. G., Kim, H. S., Chang, W. Y., Bae, J. M., Kim, W. H., & Kang, G. H. (2018). Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression. The American Journal of Pathology, 188(10), 2236\u20132250. https:\/\/doi.org\/10.1016\/j.ajpath.2018.06.012","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10239_CR61","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1038\/s41598-022-15234-2","volume":"12","author":"H Kim","year":"2022","unstructured":"Kim, H., Lee, D. H., Park, E., Myung, J. K., Park, J. H., Kim, D. I., Kim, S. I., Lee, M., Kim, Y., Park, C. M., Hyun, C. L., Maeng, Y. H., Lee, C., & Jang, B. (2022). Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis. Scientific Reports, 12(1), 11200. https:\/\/doi.org\/10.1038\/s41598-022-15234-2","journal-title":"Scientific Reports"},{"issue":"16","key":"10239_CR62","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.3390\/ijms241612746","volume":"24","author":"N I\u017cycka","year":"2023","unstructured":"I\u017cycka, N., Zaborowski, M. P., Ciecierski, \u0141, Jaz, K., Szubert, S., Miedziarek, C., Rezler, M., Pi\u0105tek-Bajan, K., Synakiewicz, A., Jankowska, A., Figlerowicz, M., Sterzy\u0144ska, K., & Nowak-Markwitz, E. (2023). Cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis. International Journal of Molecular Sciences, 24(16), 12746. https:\/\/doi.org\/10.3390\/ijms241612746","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10239_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12885-019-5327-8","volume":"19","author":"S Rot","year":"2019","unstructured":"Rot, S., Kaune, T., Taubert, H., Greither, T., Kotrba, J., G\u00fcttler, A., Wichmann, H., Bilkenroth, U., Wienke, A., Al-Nawas, B., Bache, M., Vordermark, D., Wickenhauser, C., Bethmann, D., Eckert, A. W., & Kappler, M. (2019). Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. BMC Cancer, 19(1), 155. https:\/\/doi.org\/10.1186\/s12885-019-5327-8","journal-title":"BMC Cancer"},{"issue":"28","key":"10239_CR64","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1073\/pnas.1106083108","volume":"108","author":"KS Carmon","year":"2011","unstructured":"Carmon, K. S., Gong, X., Lin, Q., Thomas, A., & Liu, Q. (2011). R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/\u03b2-catenin signaling. Proceedings of the National Academy of Sciences, 108(28), 11452\u201311457. https:\/\/doi.org\/10.1073\/pnas.1106083108","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10239_CR65","doi-asserted-by":"publisher","unstructured":"Li, Y., Zhang, R., & Hei, H. (2023). Advances in post-translational modifications of proteins and cancer immunotherapy [Review]. Frontiers in Immunology, 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1229397","DOI":"10.3389\/fimmu.2023.1229397"},{"key":"10239_CR66","doi-asserted-by":"publisher","unstructured":"Ling, H.,\u00a0Fabbri, M., & Calin, G. A. (2013). MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat\u00a0Rev Drug Discov, 12(11), 847\u2013865. https:\/\/doi.org\/10.1038\/nrd4140.","DOI":"10.1038\/nrd4140"},{"key":"10239_CR67","doi-asserted-by":"publisher","unstructured":"Corbett, A. H.\u00a0(2018). Post-transcriptional regulation of gene expression and human disease. Curr Opin Cell Biol, 52, 96-104.\u00a0https:\/\/doi.org\/10.1016\/j.ceb.2018.02.011","DOI":"10.1016\/j.ceb.2018.02.011"},{"key":"10239_CR68","doi-asserted-by":"publisher","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023). Hypoxic microenvironment in\u00a0cancer: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy, 8(1potentially inhibit LGR5 protein expression through post-translational mechanisms), 70.\u00a0https:\/\/doi.org\/10.1038\/s41392-023-01332-8.","DOI":"10.1038\/s41392-023-01332-8"},{"key":"10239_CR69","doi-asserted-by":"publisher","unstructured":"Morgan, R. G., Moln\u00e1r, E., Jones, R. F., Collard, T. J., Lane, J. D., Greenhough, A., Paraskeva, C., & Williams, A. C. (2015). Nutrient stress alters the\u00a0glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells:\u00a0implications for targeting cancer stem cells. Br J Cancer, 112(4), 714\u2013719. https:\/\/doi.org\/10.1038\/bjc.2015.4.","DOI":"10.1038\/bjc.2015.4"},{"issue":"1","key":"10239_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12885-020-06986-z","volume":"20","author":"C Hagerling","year":"2020","unstructured":"Hagerling, C., Owyong, M., Sitarama, V., Wang, C.-Y., Lin, C., van den Bijgaart, R. J. E., Koopman, C. D., Brenot, A., Nanjaraj, A., W\u00e4rnberg, F., Jirstr\u00f6m, K., Klein, O. D., Werb, Z., & Plaks, V. (2020). LGR5 in breast cancer and ductal carcinoma in situ: A diagnostic and prognostic biomarker and a therapeutic target. BMC Cancer, 20(1), 542. https:\/\/doi.org\/10.1186\/s12885-020-06986-z","journal-title":"BMC Cancer"},{"issue":"10","key":"10239_CR71","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s11064-016-1977-y","volume":"41","author":"X Chen","year":"2016","unstructured":"Chen, X., Hao, J., Fu, T., Liu, J., Yu, M., He, S., Qian, R., & Zhang, F. (2016). Temporal and Spatial Expression of LGR5 After Acute Spinal Cord Injury in Adult Rats. Neurochemical Research, 41(10), 2645\u20132654. https:\/\/doi.org\/10.1007\/s11064-016-1977-y","journal-title":"Neurochemical Research"},{"issue":"31","key":"10239_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/or.2013.2826","volume":"Jan.","author":"D Wang","year":"2014","unstructured":"Wang, D., Zhou, J., Fan, C., Jiao, F., Liu, B., Sun, P., Miao, J., & Zhang, Q. (2014). Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo. Oncology Reports, 31(1), 41\u201349. https:\/\/doi.org\/10.3892\/or.2013.2826","journal-title":"Oncology Reports"},{"issue":"1","key":"10239_CR73","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1750-3639.2012.00618.x","volume":"23","author":"S Nakata","year":"2013","unstructured":"Nakata, S., Campos, B., Bageritz, J., Bermejo, J. L., Becker, N., Engel, F., Acker, T., Momma, S., Herold-Mende, C., Lichter, P., Radlwimmer, B., & Goidts, V. (2013). LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathology, 23(1), 60\u201372. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00618.x","journal-title":"Brain Pathology"},{"issue":"10","key":"10239_CR74","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1002\/stem.2083","volume":"33","author":"L Yang","year":"2015","unstructured":"Yang, L., Tang, H., Kong, Y., Xie, X., Chen, J., Song, C., Liu, X., Ye, F., Li, N., Wang, N., & Xie, X. (2015). LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt\/\u03b2-Catenin Signaling. Stem Cells, 33(10), 2913\u20132924. https:\/\/doi.org\/10.1002\/stem.2083","journal-title":"Stem Cells"},{"issue":"4","key":"10239_CR75","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/carcin\/bgt377","volume":"35","author":"D Hirsch","year":"2014","unstructured":"Hirsch, D., Barker, N., McNeil, N., Hu, Y., Camps, J., McKinnon, K., Clevers, H., Ried, T., & Gaiser, T. (2014). LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis, 35(4), 849\u2013858. https:\/\/doi.org\/10.1093\/carcin\/bgt377","journal-title":"Carcinogenesis"},{"issue":"5","key":"10239_CR76","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.biopha.2014.03.016","volume":"68","author":"S He","year":"2014","unstructured":"He, S., Zhou, H., Zhu, X., Hu, S., Fei, M., Wan, D., Gu, W., Yang, X., Shi, D., Zhou, J., Zhou, J., Zhu, Z., Wang, L., Li, D., & Zhang, Y. (2014). Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. Biomedicine & Pharmacotherapy, 68(5), 507\u2013513. https:\/\/doi.org\/10.1016\/j.biopha.2014.03.016","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"10239_CR77","doi-asserted-by":"publisher","first-page":"e22733","DOI":"10.1371\/journal.pone.0022733","volume":"6","author":"F Walker","year":"2011","unstructured":"Walker, F., Zhang, H. H., Odorizzi, A., & Burgess, A. W. (2011). LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE, 6(7), e22733. https:\/\/doi.org\/10.1371\/journal.pone.0022733","journal-title":"PLoS ONE"},{"key":"10239_CR78","unstructured":"Lin, Y. U., Wu, T., Yao, Q., Zi, S., Cui, L., Yang, M., & Li, J. LGR5 promotes the proliferation of colorectal cancer cells via the Wnt\/\u03b2-catenin signaling pathway. (1792\u20131074 (Print))."},{"key":"10239_CR79","unstructured":"Hsu, H. C., Liu, Y. S., Tseng, K. C., Tan, B. C., Chen, S. J., & Chen, H. C. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer cells. (1873\u20133913 (Electronic))."},{"issue":"1","key":"10239_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/ijmm.2014.1752","volume":"34","author":"X Chen","year":"2014","unstructured":"Chen, X., Wei, B., Han, X., Zheng, Z., Huang, J., Liu, J., Huang, Y., & Wei, H. (2014). LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells. International Journal of Molecular Medicine, 34(1), 35\u201342. https:\/\/doi.org\/10.3892\/ijmm.2014.1752","journal-title":"International Journal of Molecular Medicine"},{"issue":"2","key":"10239_CR81","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4149\/neo_2014_016","volume":"61","author":"Z Liu","year":"2014","unstructured":"Liu, Z., Dai, W., Jiang, L., & Cheng, Y. (2014). Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients. Neoplasma, 61(2), 177\u2013185. https:\/\/doi.org\/10.4149\/neo_2014_016","journal-title":"Neoplasma"},{"issue":"2","key":"10239_CR82","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12013-015-0640-6","volume":"73","author":"H Jia","year":"2015","unstructured":"Jia, H., Xiang, L., Wang, Z., & Zhou, Q. (2015). A Study on the Mechanism of Low-Expressed Cancer Stem Cell Marker Lgr5 in Inhibition of the Proliferation and Invasion of Colorectal Carcinoma. Cell Biochemistry and Biophysics, 73(2), 393\u2013397. https:\/\/doi.org\/10.1007\/s12013-015-0640-6","journal-title":"Cell Biochemistry and Biophysics"},{"key":"10239_CR83","unstructured":"Zhang, S., Han, X., Wei, B., Fang, J., & Wei, H. (2016). RSPO2 enriches LGR5(+) spheroid colon cancer stem cells and promotes its metastasis by epithelial-mesenchymal transition. American journal of translational research, 8(2), 354\u2013364. https:\/\/pubmed.ncbi.nlm.nih.gov\/27158331https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4846888\/"},{"issue":"23","key":"10239_CR84","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-17-0219","volume":"77","author":"X Zhou","year":"2017","unstructured":"Zhou, X., Geng, L., Wang, D., Yi, H., Talmon, G., & Wang, J. (2017). R-Spondin1\/LGR5 Activates TGF\u03b2 Signaling and Suppresses Colon Cancer Metastasis. Cancer research, 77(23), 6589. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0219","journal-title":"Cancer research"},{"issue":"2","key":"10239_CR85","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3892\/mmr.2018.9191","volume":"18","author":"N Jing","year":"2018","unstructured":"Jing, N., Huang, T., Guo, H., Yang, J., Li, M., Chen, Z., & Zhang, Y. (2018). LncRNA CASC15 promotes colon cancer cell proliferation and metastasis by regulating the miR-4310\/LGR5\/Wnt\/\u03b2-catenin signaling pathway. Molecular Medicine Reports, 18(2), 2269. https:\/\/doi.org\/10.3892\/mmr.2018.9191","journal-title":"Molecular Medicine Reports"},{"key":"10239_CR86","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1477-7819-10-244","volume":"10","author":"XS Wu","year":"2012","unstructured":"Wu, X. S., Xi, H. Q., & Chen, L. (2012). Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol, 10, 244. https:\/\/doi.org\/10.1186\/1477-7819-10-244","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10239_CR87","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/nu11020326","volume":"11","author":"CV Pereira","year":"2019","unstructured":"Pereira, C. V., Duarte, M., Silva, P., Bento da Silva, A., Duarte, C. M. M., Cifuentes, A., Garc\u00eda-Ca\u00f1as, V., Bronze, M. R., Albuquerque, C., & Serra, A. T. (2019). Polymethoxylated Flavones Target Cancer Stemness and Improve the Antiproliferative Effect of 5-Fluorouracil in a 3D Cell Model of Colorectal Cancer. Nutrients, 11(2), 326. https:\/\/doi.org\/10.3390\/nu11020326","journal-title":"Nutrients"},{"issue":"1","key":"10239_CR88","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cbin.11926","volume":"47","author":"Q-T Zou","year":"2023","unstructured":"Zou, Q.-T., Lin, Y., & Luo, Q.-Y. (2023). miR-138\u20135p inhibits the progression of colorectal cancer via regulating SP1\/LGR5 axis. Cell Biology International, 47(1), 273\u2013282. https:\/\/doi.org\/10.1002\/cbin.11926","journal-title":"Cell Biology International"},{"issue":"2","key":"10239_CR89","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/carcin\/bgv250","volume":"37","author":"E Kim","year":"2015","unstructured":"Kim, E., Davidson, L. A., Zoh, R. S., Hensel, M. E., Patil, B. S., Jayaprakasha, G. K., Callaway, E. S., Allred, C. D., Turner, N. D., Weeks, B. R., & Chapkin, R. S. (2015). Homeostatic responses of colonic LGR5 + stem cells following acute in vivo exposure to a genotoxic carcinogen. Carcinogenesis, 37(2), 206\u2013214. https:\/\/doi.org\/10.1093\/carcin\/bgv250","journal-title":"Carcinogenesis"},{"issue":"4","key":"10239_CR90","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/cbt.5.4.2521","volume":"5","author":"T McClanahan","year":"2006","unstructured":"McClanahan, T., Koseoglu, S., Smith, K., Grein, J., Gustafson, E., Black, S., Kirschmeier, P., & Samatar, A. A. (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biology & Therapy, 5(4), 419\u2013426. https:\/\/doi.org\/10.4161\/cbt.5.4.2521","journal-title":"Cancer Biology & Therapy"},{"issue":"4","key":"10239_CR91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/bjc.2017.412","volume":"118","author":"RG Morgan","year":"2018","unstructured":"Morgan, R. G., Mortensson, E., Legge, D. N., Gupta, B., Collard, T. J., Greenhough, A., & Williams, A. C. (2018). LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity. British Journal of Cancer, 118(4), 558\u2013565. https:\/\/doi.org\/10.1038\/bjc.2017.412","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10239_CR92","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1007\/s13277-015-3357-7","volume":"36","author":"H Ding","year":"2015","unstructured":"Ding, H., & Wang, C. (2015). Role of Lgr5-positive cells in colorectal cancer. Tumor Biology, 36(9), 6759\u20136764. https:\/\/doi.org\/10.1007\/s13277-015-3357-7","journal-title":"Tumor Biology"},{"issue":"2","key":"10239_CR93","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1159\/000488743","volume":"46","author":"Z Leng","year":"2018","unstructured":"Leng, Z., Xia, Q., Chen, J., Li, Y., Xu, J., Zhao, E., Zheng, H., Ai, W., & Dong, J. (2018). Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Cellular Physiology and Biochemistry, 46(2), 860\u2013872. https:\/\/doi.org\/10.1159\/000488743","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10239_CR94","doi-asserted-by":"publisher","first-page":"101853","DOI":"10.1016\/j.tranon.2023.101853","volume":"Feb:40:","author":"C Li","year":"2024","unstructured":"Li, C., Yang, X., Cheng, Y., & Wang, J. (2024). LGR5, a prognostic stem cell target, promotes endometrial cancer proliferation through autophagy activation. Transl Oncol, 40, 101853. https:\/\/doi.org\/10.1016\/j.tranon.2023.101853","journal-title":"Transl Oncol"},{"issue":"12","key":"10239_CR95","doi-asserted-by":"publisher","first-page":"e0168904","DOI":"10.1371\/journal.pone.0168904","volume":"11","author":"B Wang","year":"2016","unstructured":"Wang, B., Chen, Q., Cao, Y., Ma, X., Yin, C., Jia, Y., Zang, A., & Fan, W. (2016). LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. PLoS ONE, 11(12), e0168904. https:\/\/doi.org\/10.1371\/journal.pone.0168904","journal-title":"PLoS ONE"},{"issue":"9","key":"10239_CR96","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/mc.22656","volume":"56","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Guo, X., Zhang, D., Fan, Y., Qin, L., Dong, S., & Zhang, L. (2017). Upregulated miR-132 in Lgr5(+) gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1\/CREB\/ABCG2 signaling pathway. Molecular Carcinogenesis, 56(9), 2022\u20132034. https:\/\/doi.org\/10.1002\/mc.22656","journal-title":"Molecular Carcinogenesis"},{"issue":"12","key":"10239_CR97","doi-asserted-by":"publisher","first-page":"e82390","DOI":"10.1371\/journal.pone.0082390","volume":"8","author":"BG Jang","year":"2013","unstructured":"Jang, B. G., Lee, B. L., & Kim, W. H. (2013). Distribution of LGR5+ Cells and Associated Implications during the Early Stage of Gastric Tumorigenesis. PLoS ONE, 8(12), e82390. https:\/\/doi.org\/10.1371\/journal.pone.0082390","journal-title":"PLoS ONE"},{"issue":"6","key":"10239_CR98","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1159\/000430205","volume":"36","author":"Z Wang","year":"2015","unstructured":"Wang, Z., & Liu, C. (2015). Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer. Cellular Physiology and Biochemistry, 36(6), 2447\u20132455. https:\/\/doi.org\/10.1159\/000430205","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10239_CR99","doi-asserted-by":"publisher","first-page":"109972","DOI":"10.1016\/j.cellsig.2021.109972","volume":"82","author":"S Akbari","year":"2021","unstructured":"Akbari, S., Kunter, I., Azbazdar, Y., Ozhan, G., Atabey, N., Firtina Karagonlar, Z., & Erdal, E. (2021). LGR5\/R-Spo1\/Wnt3a axis promotes stemness and aggressive phenotype in hepatoblast-like hepatocellular carcinoma cell lines. Cellular Signalling, 82, 109972. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109972","journal-title":"Cellular Signalling"},{"issue":"3","key":"10239_CR100","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yexcr.2012.10.011","volume":"319","author":"M Fukuma","year":"2013","unstructured":"Fukuma, M., Tanese, K., Effendi, K., Yamazaki, K., Masugi, Y., Suda, M., & Sakamoto, M. (2013). Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells. Experimental Cell Research, 319(3), 113\u2013121. https:\/\/doi.org\/10.1016\/j.yexcr.2012.10.011","journal-title":"Experimental Cell Research"},{"issue":"37","key":"10239_CR101","doi-asserted-by":"publisher","first-page":"40053","DOI":"10.18632\/oncotarget.5548","volume":"6","author":"GC Vieira","year":"2015","unstructured":"Vieira, G. C., Chockalingam, S., Melegh, Z., Greenhough, A., Malik, S., Szemes, M., Park, J. H., Kaidi, A., Zhou, L., Catchpoole, D., Morgan, R., Bates, D. O., Gabb, P. D., & Malik, K. (2015). LGR5 regulates pro-survival MEK\/ERK and proliferative Wnt\/\u03b2-catenin signalling in neuroblastoma. Oncotarget, 6(37), 40053\u201340067. https:\/\/doi.org\/10.18632\/oncotarget.5548","journal-title":"Oncotarget"},{"issue":"36","key":"10239_CR102","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.1074\/jbc.M117.786798","volume":"292","author":"KS Carmon","year":"2017","unstructured":"Carmon, K. S., Gong, X., Yi, J., Wu, L., Thomas, A., Moore, C. M., Masuho, I., Timson, D. J., Martemyanov, K. A., & Liu, Q. J. (2017). LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway. The Journal of Biological Chemistry, 292(36), 14989\u201315001. https:\/\/doi.org\/10.1074\/jbc.M117.786798","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10239_CR103","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-024-47227-2","volume":"15","author":"S Conti","year":"2024","unstructured":"Conti, S., Venturini, V., Ca\u00f1ellas-Socias, A., Cortina, C., Abenza, J. F., Stephan-Otto Attolini, C., Middendorp Guerra, E., Xu, C. K., Li, J. H., Rossetti, L., Stassi, G., Roca-Cusachs, P., Diz-Mu\u00f1oz, A., Ruprecht, V., Guck, J., Batlle, E., Labernadie, A., & Trepat, X. (2024). Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells. Nature Communications, 15(1), 3363. https:\/\/doi.org\/10.1038\/s41467-024-47227-2","journal-title":"Nature Communications"},{"issue":"4","key":"10239_CR104","first-page":"1572","volume":"7","author":"FJ Gao","year":"2014","unstructured":"Gao, F. J., Chen, J. Y., Wu, H. Y., Shi, J., Chen, M., Fan, X. S., & Huang, Q. (2014). Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer. International Journal of Clinical and Experimental Pathology, 7(4), 1572\u20131579.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"53","key":"10239_CR105","doi-asserted-by":"publisher","first-page":"30025","DOI":"10.18632\/oncotarget.23144","volume":"9","author":"Z Zheng","year":"2018","unstructured":"Zheng, Z., Yu, H., Huang, Q., Wu, H., Fu, Y., Shi, J., Wang, T., & Fan, X. (2018). Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma. Oncotarget, 9(53), 30025\u201330033. https:\/\/doi.org\/10.18632\/oncotarget.23144","journal-title":"Oncotarget"},{"issue":"6","key":"10239_CR106","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3889\/oamjms.2018.208","volume":"6","author":"S Rosiq","year":"2018","unstructured":"Rosiq, S., Hammam, O., Abdelalim, A., Anas, A., Khalil, H., & Amer, M. (2018). Colonic Stem Cells Expression of Lgr5 and CD133 Proteins as Predictive Markers in Colorectal Cancer among Egyptian Patients. Open Access Macedonian Journal of Medical Sciences, 6(6), 968\u2013974. https:\/\/doi.org\/10.3889\/oamjms.2018.208","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"issue":"4","key":"10239_CR107","first-page":"327","volume":"4","author":"B Kleist","year":"2011","unstructured":"Kleist, B., Xu, L., Li, G., & Kersten, C. (2011). Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. International Journal of Clinical and Experimental Pathology, 4(4), 327\u2013335.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"4","key":"10239_CR108","doi-asserted-by":"publisher","first-page":"412","DOI":"10.22088\/cjim.10.4.411","volume":"10","author":"R Shekarriz","year":"2019","unstructured":"Shekarriz, R., Montazer, F., & Alizadeh-Navaei, R. (2019). Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with clinicopathological findings. Caspian Journal of Internal Medicine, 10(4), 412\u2013416. https:\/\/doi.org\/10.22088\/cjim.10.4.411","journal-title":"Caspian Journal of Internal Medicine"},{"issue":"2","key":"10239_CR109","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/mco.2016.934","volume":"5","author":"X Zhang","year":"2016","unstructured":"Zhang, X., Xu, M., Su, S., Zhou, Z., Yang, H., Zhao, S., Zeng, D., Yang, K., Liu, Y., Wang, L., & Li, J. (2016). Lgr5-positive cells in the lung and their clinical significance in patients with lung adenocarcinoma. Mol Clin Oncol, 5(2), 283\u2013288. https:\/\/doi.org\/10.3892\/mco.2016.934","journal-title":"Mol Clin Oncol"},{"issue":"33","key":"10239_CR110","doi-asserted-by":"publisher","first-page":"34549","DOI":"10.18632\/oncotarget.5330","volume":"6","author":"G Michelotti","year":"2015","unstructured":"Michelotti, G., Jiang, X., Sosa, J. A., Diehl, A. M., & Henderson, B. B. (2015). LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. Oncotarget, 6(33), 34549\u201334560. https:\/\/doi.org\/10.18632\/oncotarget.5330","journal-title":"Oncotarget"},{"key":"10239_CR111","doi-asserted-by":"publisher","unstructured":"Wang, W., Wan, L., Wu, S., Yang, J., Zhou, Y., Liu, F., Wu, Z., & Cheng, Y. (2018). Mesenchymal marker and LGR5\u00a0expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Cellular Oncology (Dordrecht),\u00a041(5), 495\u2013504. https:\/\/doi.org\/10.1007\/s13402-018-0386-4.","DOI":"10.1007\/s13402-018-0386-4"},{"key":"10239_CR112","doi-asserted-by":"publisher","unstructured":"Fumagalli, A., Oost, K. C., Kester, L., Morgner, J., Bornes, L., Bruens, L., Spaargaren, L., Azkanaz, M., Schelfhorst, T., Beerling, E., Heinz, M. C., Postrach, D., Seinstra, D., Sieuwerts, A. M., Martens, J. W. M., van der Elst, S., van Baalen, M., Bhowmick, D., Vrisekoop, N., . . . van Rheenen, J. (2020). Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell, 26(4), 569\u2013578.e567. https:\/\/doi.org\/10.1016\/j.stem.2020.02.008","DOI":"10.1016\/j.stem.2020.02.008"},{"key":"10239_CR113","doi-asserted-by":"publisher","first-page":"8154926","DOI":"10.1155\/2019\/8154926","volume":"2019","author":"A Freiin Grote","year":"2019","unstructured":"Freiin Grote, A., Halske, C., Behrens, H. M., Kr\u00fcger, S., Wilhelm, F., Egberts, J. H., & R\u00f6cken, C. (2019). Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response. Disease Markers, 2019, 8154926. https:\/\/doi.org\/10.1155\/2019\/8154926","journal-title":"Disease Markers"},{"issue":"19","key":"10239_CR114","doi-asserted-by":"publisher","first-page":"31581","DOI":"10.18632\/oncotarget.15770","volume":"8","author":"HQ Xi","year":"2017","unstructured":"Xi, H. Q., Zhang, K. C., Li, J. Y., Cui, J. X., Gao, Y. H., Wei, B., Huang, D., & Chen, L. (2017). RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer. Oncotarget, 8(19), 31581\u201331591. https:\/\/doi.org\/10.18632\/oncotarget.15770","journal-title":"Oncotarget"},{"issue":"11","key":"10239_CR115","first-page":"11267","volume":"10","author":"Z Wu","year":"2017","unstructured":"Wu, Z., Song, W., Cheng, Z., Yang, D., & Yu, L. (2017). Expression of LGR5 in oral squamous cell carcinoma and its correlation to vasculogenic mimicry. International Journal of Clinical and Experimental Pathology, 10(11), 11267\u201311275.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"3","key":"10239_CR116","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cellsig.2013.11.032","volume":"26","author":"M Krausova","year":"2014","unstructured":"Krausova, M., & Korinek, V. (2014). Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling, 26(3), 570\u2013579. https:\/\/doi.org\/10.1016\/j.cellsig.2013.11.032","journal-title":"Cellular Signalling"},{"key":"10239_CR117","doi-asserted-by":"publisher","unstructured":"Liz\u00e1rraga-Verdugo, E., Avenda\u00f1o-F\u00e9lix, M., Berm\u00fadez, M., Ramos-Pay\u00e1n, R., P\u00e9rez-Plasencia, C., & Aguilar-Medina, M. (2020). Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers [Mini Review]. Frontiers in Oncology, 10. https:\/\/doi.org\/10.3389\/fonc.2020.00413","DOI":"10.3389\/fonc.2020.00413"},{"issue":"4","key":"10239_CR118","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.3390\/ijms13044367","volume":"13","author":"M Valladares-Ayerbes","year":"2012","unstructured":"Valladares-Ayerbes, M., Blanco-Calvo, M., Reboredo, M., Lorenzo-Pati\u00f1o, M. J., Iglesias-D\u00edaz, P., Haz, M., D\u00edaz-Prado, S., Medina, V., Santamarina, I., P\u00e9rtega, S., Figueroa, A., & Ant\u00f3n-Aparicio, L. M. (2012). Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer. International Journal of Molecular Sciences, 13(4), 4367\u20134387. https:\/\/doi.org\/10.3390\/ijms13044367","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10239_CR119","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12885-018-4018-1","volume":"18","author":"MF Hou","year":"2018","unstructured":"Hou, M. F., Chen, P. M., & Chu, P. Y. (2018). LGR5 overexpression confers poor relapse-free survival in breast cancer patients. BMC Cancer, 18(1), 219. https:\/\/doi.org\/10.1186\/s12885-018-4018-1","journal-title":"BMC Cancer"},{"issue":"5","key":"10239_CR120","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jim-2018-000934","volume":"67","author":"Y Jia","year":"2019","unstructured":"Jia, Y., Li, Z., Cheng, X., Wu, X., Pang, F., Shi, J., Shen, L., Li, X., Hu, Y., Zhang, L., & Ji, J. (2019). Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the \u03b2-catenin\/LGR5\/Bcl-2 axis. Journal of Investigative Medicine, 67(5), 856. https:\/\/doi.org\/10.1136\/jim-2018-000934","journal-title":"Journal of Investigative Medicine"},{"issue":"2","key":"10239_CR121","doi-asserted-by":"publisher","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","volume":"106","author":"DR Principe","year":"2014","unstructured":"Principe, D. R., Doll, J. A., Bauer, J., Jung, B., Munshi, H. G., Bartholin, L., Pasche, B., Lee, C., & Grippo, P. J. (2014). TGF-\u03b2: Duality of function between tumor prevention and carcinogenesis. Journal of the National Cancer Institute, 106(2), djt369. https:\/\/doi.org\/10.1093\/jnci\/djt369","journal-title":"Journal of the National Cancer Institute"},{"key":"10239_CR122","doi-asserted-by":"publisher","unstructured":"Liu, X.-S., Lin, X.-K., Mei, Y., Ahmad, S., Yan, C.-X., Jin, H.-L., Yu, H., Chen, C., Lin, C.-Z., & Yu, J.-R. (2019). Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer. Frontiers in Immunology, 10,1741. https:\/\/doi.org\/10.3389\/fimmu.2019.01741","DOI":"10.3389\/fimmu.2019.01741"},{"key":"10239_CR123","doi-asserted-by":"publisher","unstructured":"Chen Z, Xue C. (2019) G-Protein-Coupled Receptor 5 (LGR5)\u00a0Overexpression Activates \u03b2-Catenin Signaling in Breast Cancer Cells via Protein\u00a0Kinase A. Med Sci Monit Basic Res, 25, 15\u201325. https:\/\/doi.org\/10.12659\/MSMBR.912411.\u00a0","DOI":"10.12659\/MSMBR.912411"},{"issue":"11","key":"10239_CR124","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1158\/1541-7786.Mcr-19-0436","volume":"17","author":"S Zhang","year":"2019","unstructured":"Zhang, S., Chatterjee, T., Godoy, C., Wu, L., Liu, Q. J., & Carmon, K. S. (2019). GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Molecular Cancer Research, 17(11), 2196\u20132207. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0436","journal-title":"Molecular Cancer Research"},{"key":"10239_CR125","doi-asserted-by":"crossref","unstructured":"Xi HQ, Cui JX, Shen WS, Wu XS, Bian SB, Li JY, Song Z, Wei B, Chen L. [Corrigendum] (2019). Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer. Oncol Rep. 2019 42(1), 462. doi: 10.3892\/or.2019.7120.","DOI":"10.3892\/or.2019.7120"},{"issue":"1","key":"10239_CR126","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4149\/neo_2017_110","volume":"64","author":"H Hou","year":"2017","unstructured":"Hou, H., Kang, Y., Li, Y., Zeng, Y., Ding, G., & Shang, J. (2017). miR-33a expression sensitizes Lgr5+ HCC-CSCs to doxorubicin via ABCA1. Neoplasma, 64(1), 81\u201391. https:\/\/doi.org\/10.4149\/neo_2017_110","journal-title":"Neoplasma"},{"issue":"9","key":"10239_CR127","doi-asserted-by":"publisher","first-page":"e04820","DOI":"10.1016\/j.heliyon.2020.e04820","volume":"6","author":"A Behera","year":"2020","unstructured":"Behera, A., Ashraf, R., Srivastava, A. K., & Kumar, S. (2020). Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells. Heliyon, 6(9), e04820. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04820","journal-title":"Heliyon"},{"key":"10239_CR128","doi-asserted-by":"publisher","first-page":"106051","DOI":"10.1016\/j.biocel.2021.106051","volume":"138","author":"S Bindhya","year":"2021","unstructured":"Bindhya, S., Sidhanth, C., Krishnapriya, S., Garg, M., & Ganesan, T. S. (2021). Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer. The International Journal of Biochemistry & Cell Biology, 138, 106051. https:\/\/doi.org\/10.1016\/j.biocel.2021.106051","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"2","key":"10239_CR129","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.taap.2015.07.025","volume":"288","author":"TC Chang","year":"2015","unstructured":"Chang, T. C., Yeh, C. T., Adebayo, B. O., Lin, Y. C., Deng, L., Rao, Y. K., Huang, C. C., Lee, W. H., Wu, A. T., Hsiao, M., Wu, C. H., Wang, L. S., & Tzeng, Y. M. (2015). 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype. Toxicology and Applied Pharmacology, 288(2), 258\u2013268. https:\/\/doi.org\/10.1016\/j.taap.2015.07.025","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"314","key":"10239_CR130","doi-asserted-by":"publisher","first-page":"314186","DOI":"10.1126\/scitranslmed.aac7433","volume":"7","author":"MR Junttila","year":"2015","unstructured":"Junttila, M. R., Mao, W., Wang, X., Wang, B. E., Pham, T., Flygare, J., Yu, S. F., Yee, S., Goldenberg, D., Fields, C., Eastham-Anderson, J., Singh, M., Vij, R., Hongo, J. A., Firestein, R., Schutten, M., Flagella, K., Polakis, P., & Polson, A. G. (2015). Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer. Science Translational Medicine, 7(314), 314186. https:\/\/doi.org\/10.1126\/scitranslmed.aac7433","journal-title":"Science Translational Medicine"},{"key":"10239_CR131","doi-asserted-by":"crossref","unstructured":"Daniel J. Inglis, J. L., Kristen R. Georgiou, Nicole L. Wittwer, Ross W. Hamilton, Donna M. Beaumont, Michaela A. Scherer, Tina C. Lavranos. (2018). Characterization of BNC101 a human specific monoclonal antibody targeting the GPCR LGR5: First-in-human evidence of target engagement [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018. Retrieved 7.4 from https:\/\/aacrjournals.org\/cancerres\/article\/78\/13_Supplement\/3910\/628247\/Abstract-3910-Characterization-of-BNC101-a-human","DOI":"10.1158\/1538-7445.AM2018-3910"},{"issue":"3","key":"10239_CR132","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11418-021-01505-1","volume":"75","author":"X Mao","year":"2021","unstructured":"Mao, X., Zhang, X., Zheng, X., Chen, Y., Xuan, Z., & Huang, P. (2021). Curcumin suppresses LGR5(+) colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway. Journal of Natural Medicines, 75(3), 590\u2013601. https:\/\/doi.org\/10.1007\/s11418-021-01505-1","journal-title":"Journal of Natural Medicines"},{"key":"10239_CR133","unstructured":"Wanqi Wang, V. B., Noor A. Lokman, Silvana Napoli, Batjargal Gundsambuu, Martin K. Oehler, Simon C. Barry, Carmela Ricciardelli. (2022). LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer. AACR Annual Meeting 2022. Retrieved 7.4 from https:\/\/www.abstractsonline.com\/pp8\/#!\/10517\/presentation\/17504"},{"issue":"3","key":"10239_CR134","doi-asserted-by":"publisher","first-page":"e102771","DOI":"10.15252\/embj.2019102771","volume":"39","author":"L Novellasdemunt","year":"2020","unstructured":"Novellasdemunt, L., Kucharska, A., Jamieson, C., Prange-Barczynska, M., Baulies, A., Antas, P., van der Vaart, J., Gehart, H., Maurice, M. M., & Li, V. S. (2020). NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor. The EMBO Journal, 39(3), e102771. https:\/\/doi.org\/10.15252\/embj.2019102771","journal-title":"The EMBO Journal"},{"issue":"7","key":"10239_CR135","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/1535-7163.Mct-17-0694","volume":"17","author":"J Cao","year":"2018","unstructured":"Cao, J., Li, C., Wei, X., Tu, M., Zhang, Y., Xu, F., & Xu, Y. (2018). Selective Targeting and Eradication of LGR5(+) Cancer Stem Cells Using RSPO-Conjugated Doxorubicin Liposomes. Molecular Cancer Therapeutics, 17(7), 1475\u20131485. https:\/\/doi.org\/10.1158\/1535-7163.Mct-17-0694","journal-title":"Molecular Cancer Therapeutics"},{"issue":"6","key":"10239_CR136","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3892\/or.2015.4290","volume":"34","author":"J Miao","year":"2015","unstructured":"Miao, J., Jiang, Y., Wang, D., Zhou, J., Fan, C., Jiao, F., Liu, B. O., Zhang, J. U. N., Wang, Y., & Zhang, Q. (2015). Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt\/\u03b2-catenin signaling pathway. Oncology Reports, 34(6), 2845. https:\/\/doi.org\/10.3892\/or.2015.4290","journal-title":"Oncology Reports"},{"issue":"54","key":"10239_CR137","doi-asserted-by":"publisher","first-page":"92743","DOI":"10.18632\/oncotarget.21574","volume":"8","author":"K Carter","year":"2017","unstructured":"Carter, K., Rameshwar, P., Ratajczak, M. Z., & Kakar, S. S. (2017). Verrucarin J inhibits ovarian cancer and targets cancer stem cells. Oncotarget, 8(54), 92743\u201392756. https:\/\/doi.org\/10.18632\/oncotarget.21574","journal-title":"Oncotarget"},{"issue":"4","key":"10239_CR138","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12015-019-09874-7","volume":"15","author":"K Udoh","year":"2019","unstructured":"Udoh, K., Parte, S., Carter, K., Mack, A., & Kakar, S. S. (2019). Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin. Stem Cell Reviews and Reports, 15(4), 601\u2013611. https:\/\/doi.org\/10.1007\/s12015-019-09874-7","journal-title":"Stem Cell Reviews and Reports"},{"key":"10239_CR139","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2147\/ijn.S440881","volume":"19","author":"A Cepero","year":"2024","unstructured":"Cepero, A., Jim\u00e9nez-Carretero, M., Jabalera, Y., Gago, L., Luque, C., Cabeza, L., Melguizo, C., Jimenez-Lopez, C., & Prados, J. (2024). LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy. International Journal of Nanomedicine, 19, 1843\u20131865. https:\/\/doi.org\/10.2147\/ijn.S440881","journal-title":"International Journal of Nanomedicine"},{"issue":"2","key":"10239_CR140","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1124\/jpet.122.001495","volume":"385","author":"C Wong","year":"2023","unstructured":"Wong, C., Mulero, M. C., Barth, E. I., Wang, K., Shang, X., Tikle, S., Rice, C., Gately, D., & Howell, S. B. (2023). Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian Cancer. Journal of Pharmacology and Experimental Therapeutics, 385(2), 95\u2013105. https:\/\/doi.org\/10.1124\/jpet.122.001495","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10239_CR141","unstructured":"Veronika Bandara, S. M., Emma Thompson, Lih Tan, Batjargal Gundsambuu, Silvana Napoli, Jade Foeng, Dylan McPeake, Justin Coombs, Allison Cowin, Claudine Bonder, Timothy Sadlon, Shaun McColl, Simon Barry. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer. AACR Annual Meeting 2022. Retrieved 7.4 from https:\/\/www.abstractsonline.com\/pp8\/#!\/10517\/presentation\/18684"},{"issue":"8","key":"10239_CR142","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/embor.2013.92","volume":"14","author":"FDSE Melo","year":"2013","unstructured":"Melo, F. D. S. E., Vermeulen, L., Fessler, E., & Medema, J. P. (2013). Cancer heterogeneity\u2014a multifaceted view. EMBO Reports, 14(8), 686\u2013695. https:\/\/doi.org\/10.1038\/embor.2013.92","journal-title":"EMBO Reports"},{"issue":"7","key":"10239_CR143","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/cells12070990","volume":"12","author":"W Groenewald","year":"2023","unstructured":"Groenewald, W., Lund, A. H., & Gay, D. M. (2023). The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options. Cells, 12(7), 990. https:\/\/doi.org\/10.3390\/cells12070990","journal-title":"Cells"},{"issue":"6","key":"10239_CR144","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H., & Nusse, R. (2012). Wnt\/\u03b2-Catenin Signaling and Disease. Cell, 149(6), 1192\u20131205. https:\/\/doi.org\/10.1016\/j.cell.2012.05.012","journal-title":"Cell"},{"issue":"2","key":"10239_CR145","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/mol.119.117978","volume":"97","author":"Z Zhong","year":"2020","unstructured":"Zhong, Z., & Virshup, D. M. (2020). Wnt Signaling and Drug Resistance in Cancer. Molecular Pharmacology, 97(2), 72. https:\/\/doi.org\/10.1124\/mol.119.117978","journal-title":"Molecular Pharmacology"},{"issue":"24","key":"10239_CR146","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1073\/pnas.1508113112","volume":"112","author":"BK Koo","year":"2015","unstructured":"Koo, B. K., van Es, J. H., van den Born, M., & Clevers, H. (2015). Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia. Proc Natl Acad Sci U S A, 112(24), 7548\u20137550. https:\/\/doi.org\/10.1073\/pnas.1508113112","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-024-10239-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:58:49Z","timestamp":1743303529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-024-10239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10239"],"URL":"https:\/\/doi.org\/10.1007\/s10555-024-10239-x","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"23"}}